Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2017

Nov 13, 2017

29828_dirs_2017-11-13_642ca2cf-9f87-4478-994b-b787f468e013.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-11-09

Reporting Person: Meyers James R (EVP Worldwide Commercial Ops)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-09 Common Stock A 2700 Acquired 5415 Direct
2017-11-09 Common Stock F 1373 $73.02 Disposed 4042 Direct
2017-11-09 Common Stock G 1327 Disposed 2715 Direct
2017-11-09 Common Stock G 1327 Acquired 129760 Indirect

Footnotes

F1: Issuance of common stock upon vesting of certain performance share awards on November 9, 2017.